BMO Capital Maintains Outperform on Andersons, Raises Price Target to $90
BMO Capital analyst Benjamin Mayhew maintains Andersons (NASDAQ:ANDE) with a Outperform and raises the price target from $75 to $90.
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
BMO Capital analyst Benjamin Mayhew maintains Andersons (NASDAQ:ANDE) with a Outperform and raises the price target from $75 to $90.
Gainers Medifast (NYSE:MED) stock increased by 10.7% to $10.78 during Monday's after-market session. The market value of their outstanding shares is at $108.0 million. The company's, Q2 earnings came out today.
Filed: 2026-08-03 AccNo: 0000821026-26-000120 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits